؉ cells used for organ regeneration after untreatable damage, into inflamed glomeruli in NOD/SCID mice.
thelial stem cells [1] and neural stem cells [2] have been modified hematopoietic stem cells has been reported to confer resistance to inflammation and prevent renal injury in glomerudiscovered. Following the progression of this field of lonephritis. Although this strategy has potentials for clinical research, the potential for stem cell therapy has increased use, taking hematopoietic stem cells from bone marrow is and several therapeutic benefits have already been rehighly stressful for patients. In this regard, umbilical cord blood ported [3, 4] . Although this approach was originally may be a useful alternative and, therefore, we focused on their suitability as a source of hematopoietic stem cells for transinvestigated for fatal or hereditary diseases, we have plantation-based therapy for glomerulonephritis.
proposed that inflammatory diseases such as glomeruloMethods. CD34 ϩ cells were obtained from human umbilical nephritis are also candidates for transplantation-based cord blood, retrovirally transduced with human ␤-glucuronidase (HBG) gene, and transplanted into nonobese diabetic/ gene therapy using hematopoietic stem cells [5] . We used severe combined immunodeficiency (NOD/SCID) mice. After bone marrow-derived cells as a vehicle to deliver anticonfirming the successful chimerism, these mice were treated inflammatory molecules into inflamed glomeruli [6, 7] .
with lipopolysaccharide (LPS), and local HBG expression in
In the ex vivo differentiation system, bone marrow cells glomeruli was examined using immunohistochemical analysis, HBG bioassay, and Western blot analysis.
were differentiated ex vivo to express ligands of adhesion
Results. Clonogenic assay showed that 88.4 Ϯ 5.9% burstmolecules and acquire the potential to be recruited to forming unit-erythroid (BFU-E), 79.7 Ϯ 11.4% in colony-formthe inflamed site, and were adenovirally transfected with ing unit-macrophage (CFU-M), and 81.1 Ϯ 14.1% in colonyforming unit-granulocyte (CFU-G), respectively, possessed the a foreign gene followed by transfusion to the affected transgene after transfection, suggesting that precommited cells subjects. These cells may deliver anti-inflammatory cytowere susceptible to retroviral infection. Flow cytometric analykines into inflamed glomeruli [8] . In the in vivo differentisis revealed that 24.1 Ϯ 14.5% of bone marrow cells in these ation system, bone marrow cells were genetically modichimera mice expressed human lymphocyte antigen (HLA) 8 weeks after transplantation. Also, clonogenic assay showed fied using retrovirus and transplanted to the affected that a sustained engraftment of human hematopoietic cells subjects before differentiation so that they may retain expressed HBG. CD14-positive cells were recruited into the the potential for self-renewal, as well as differentiation, glomeruli upon LPS treatment and they secreted bioactive HBG, suggesting that cord blood-derived CD34 ϩ cells may difin vivo [7] . Both systems were able to prove the therapeuferentiate into monocyte lineage while maintaining the exprestic benefit of anti-glomerular basement membrane (antision of the transgene.
GBM) nephritis in mice [6, 7] . These strategies have
Conclusion. These data indicate that umbilical cord blood cells can be utilized as a source of hematopoietic stem cells several advantages over the previous glomerulus-tarfor the transplantation-based therapy of glomerulonephritis. geted gene delivery systems (i.e., use of peripheral vessels for administration, longer therapeutic time window, and possibly no immunoreaction due to autologous Recently, stem cell research has attracted considerable transfer) and suggest that bone marrow-derived cells attention from many researchers because it could be can be utilized for therapeutic intervention to treat local inflammation.
is highly inconvenient for patients, especially when it is for the treatment of nonlethal diseases like inflammation. In this regard, umbilical cord blood cells may be a useful sity School of Medicine (Tokyo, Japan) from breeding alternative because: (1) a substantial amount of blood pairs purchased from Jackson Laboratory (Bar Harbor, (about 100 mL from each delivery [9] ) may be corrected ME, USA). Animals were housed in a positive airflow without pain and risk to mother or infant; (2) they conventilated rack and bred and maintained under specific tain a significantly higher number of hematopoietic propathogen-free conditions. genitor cells when compared with adult peripheral blood Establishment of chimera mice [10] ; (3) lower incidence and severity of graft versus host disease (GVHD) after transplantation occurs due to the Human umbilical cord blood samples were obtained, immature immune system [10] ; and (4) recently, largewith informed consent, from placentas of full-term norscale banks of cord blood have been developed or are mal newborn infants. After isolation of mononuclear being considered throughout world. We, therefore, excells from cord blood by density gradient centrifugation amined their suitability as a source of hematopoietic with Nicoprep TM 1.077 (Nycomed Pharma AS, Oslo, Norstem cells for transplantation-based gene therapy for way), CD34 ϩ cells were obtained from mononuclear cells inflammatory diseases.
by magnetic bead separation (Dynal CD34 Progenitor To monitor the behavior of human cells in vivo, a Cell Selection System; Dynal, Lake Success, NY, USA) bone marrow repopulating system using the nonobese diaaccording to the manufacturer's instructions. These cells betic/severe combined immunodeficiency (NOD/SCID) were suspended in MyeloCult H5100 (StemCell Techmouse was applied. NOD/SCID mice are characterized nologies, Inc., Vancouver, British Columbia, Canada) by a functional deficit of natural killer cells, absence of with penicillin G (100 U/mL), streptomycin (100 g/mL), circulating complement, and defects in the differentiaand amphotericin B (0.25 g/mL) supplemented with tion and function of antigen-presenting cells (APC), as 200 units/mL human interleukin-6 (IL-6) (Kirin Brewery well as an absence of T and B cell functions, facilitating Co., Ltd., Tokyo, Japan), and 100 ng/mL human stem reconstitution with human hematopoietic cells [11, 12] .
cell factor (mSCF) (Kirin Brewery Co., Ltd.), Flt-3/Flk-2 Using transplantation techniques, chimera mice, which ligand (100 ng/mL; R & D Systems, Minneapolis, MN, have a mouse body with a human hematopoietic system, USA), human thrombopoietin (10 ng/mL; Kirin Brewery may be established.
Co., Ltd.). After cultivation in a humidified atmosphere In this study, we report that umbilical cord blood cells of 5% CO 2 at a concentration of 1 ϫ 10 6 cells/mL for 24 may be a useful alternative as a source of hematopoietic hours, the bone marrow cells were transfected with the stem cells for transplantation-based gene therapy to treat human HBG gene via a retrovirus as described later. inflammatory diseases such as glomerulonephritis.
NOD/SCID mice were prepared for transplantation with a sublethal dose of irradiation (3.5 Gy). Genetically-METHODS modified CD34 ϩ cells (5 ϫ 10 4 /20 g body weight) were infused into recipient mice via the tail vein once daily Experimental Design for 4 consecutive days. Bone marrow cells were freshly CD34 ϩ cells were obtained from human cord blood prepared for each injection. and retrovirally transfected with human ␤-glucuronidase (HBG) as a marker. Successful transfection into predifRecombinant retrovirus preparation and infection ferentiated cells was confirmed by clonogenic assay. CD34 ϩ cells were transduced with HBG via a retroviThese cells were transplanted into NOD/SCID mice, and rus using a centrifuge method [14] . wCRIP packaging 8 weeks later successful chimerism was again confirmed cells [15] producing an MFG-GC vector (1 ϫ 10 6 cfu/ by clonogenic assay and flow cytometric analysis. Since mL) expression of HBG were constructed as described we found that LPS induced adhesion molecules even in before [16] . A retroviral vector-containing supernatant the glomeruli of NOD/SCID mice (data not shown), was collected from confluent monolayers of these packthese chimera mice received 25 g LPS purified from aging cells grown in Dulbecco's modified Eagle's meKlebsiella O3 [13] or saline as a control for 7 days. Tissue dium (DMEM) with 10% calf serum (CS) (Gibco/BRL, specimens were subjected to immunohistochemical analGrand Island, NY, USA). These supernatants were filysis on human CD14 and HBG to confirm that the transtered (0.45 m) and centrifuged at 14,000 g for 2 hours planted premature cells may differentiate into monocyte at 4ЊC to concentrate the virus [17] , followed by resuslineage cells at the recruited site and those cells still pension in one-tenth the volume of culture medium. express transgene. HBG bioactivity and Western blot
After pre-stimulation with IL-6, hSCF, thrombopoietin, analysis of isolated glomeruli were also compared beand Flt-3/Flk-2 ligand for 24 hours, CD34 ϩ cells (5.0 ϫ tween LPS-treated and saline-treated mice. 10 4 /mL culture medium) were transferred into a roundAnimals bottomed tube (Falcon #2051, Franklin Lakes, NJ, USA), which was coated with a recombinant human fibronectin A breeding colony of NOD/SCID mice was established at the laboratory animal center of the Jikei Univerfragment CH-296 (Takara Shuzo Co., Ltd., Shiga, Japan) [18] , mixed with the same amount of concentrated retroTwo-color immunofluorescent staining viral vector and 8 g/mL polybrene and centrifuged at Each specimen was embedded in optimal cutting tem-1500 g at 20ЊC for 2 hours once daily for 3 days [14] .
perature (OCT) compound (Miles Scientific, Naperville, Freshly prepared retroviral vector-containing superna-IL, USA) and quickly frozen in liquid nitrogen. Cryostat tant was used for each period of infection. Between censections (6 m) were dried and fixed with acetone for 15 trifugations, the cells were incubated with culture medium minutes. After blocking the endogenous biotin with an in the presence of IL-6, hSCF, thrombopoietin, and Flt-3/ avidin/biotin blocking kit (Vector Laboratories, BurlFlk-2 ligand without transfer from the centrifuge tube.
ingame, CA, USA), the sections were incubated with After the third centrifugation, CD34 ϩ cells were washed sheep anti-human CD14 (Genzyme, Cambridge, MA, and resuspended in phosphate-buffered saline (PBS) for USA) and goat anti-human HBG (a kind gift from Dr. William S. Sly) at 4ЊC overnight and biotinylated donkey transplantation.
anti-sheep IgG (Chemicon, Temecula, CA, USA) for 2 Fluorescence cytometry hours at 37ЊC. After rinsing in PBS, the sections were incubated with Alexa Fluor rabbit anti-goat IgG (HϩL) Bone marrow cells were harvested from chimera mice conjugate (Molecular Probes, Leiden, The Netherlands) 8 weeks after transplantation and incubated with mouse and FITC-streptavidin (Becton Dickinson, Franklin immunoglobulin G (IgG) and fluorescein isothiocyaLakes, NJ, USA). The sections were mounted in p-phenate (FITC)-conjugated anti-human HLA ABC antigen nylenediamine (PD)-PBS-glycine and observed under a (Sigma, St. Louis, MO, USA) for 30 minutes and 60 minfluorescence photomicroscope. Pictures were taken using utes, respectively, at 4ЊC. Samples were analyzed on a an autoexposure camera (Zeiss, Thornwood, NY, USA). flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). Four chimera mice were analyzed individually.
HBG enzymatic activity of isolated glomeruli As a positive control, mononuclear cells from healthy HBG bioactivity of isolated glomeruli was assayed volunteers were also subjected to flow cytometric analysis.
as described [22] . Briefly, glomeruli from chimera mice transplanted with LPS or saline treatment were isolated Clonogenic assay for transduced CD34
؉ cells and homogenized in distilled water using a glass homogeClonogenic assay was performed as previously denizer. The homogenates were spun at 14,000g for 10 scribed [19] . In brief, transduced CD34 ϩ cells were plated minutes at 4ЊC. The clear supernatant was assayed fluoat a concentration of 1 ϫ 10 3 cells/mL in MethoCult rometrically for HBG activity with the synthetic fluoro-GF H4434V (methylcellulose-containing medium with genic substrate 4-methylumbelliferyl ␤-D-glucuronidase erythropoietin, stem cell factor, GM-CSF, and IL-3) (Sigma). After incubation of each sample with the sub-(StemCell Technologies, Inc.). After 14 days, CFU-G, strate for 30 minutes at 37ЊC, reactions were terminated CFU-M, and BFU-E were selected and DNA was exby the addition of 0.17mol/L glycine-carbonate buffer tracted following a previously published method [20] .
(pH 10.4). The 4-methylumbelliferone (4-MU) that had The yield of DNA was monitored by human-specific ␤ 2 formed was measured fluorometrically. Units of HBG microgloblin polymerase chain reaction (PCR) [21] . To activity are defined as nanomoles 4-MU produced/hr/mg amplify the HBG cDNA sequence, PCR was carried out protein. Protein concentration was determined with a on genomic DNA samples in a final volume of 100 L.
bicinchorinic acid (BCA) kit (Pierce, Rockford, IL, USA). The primers used for PCR were 5Ј-GAT GGT GAT CGC TCA CAC CA-3Ј and 5Ј-CGG TGA CTG TTC Immunoprecipitation of human HBG AGT CAT GA-3Ј, which amplify part of the HBG Since measurements of HBG enzymatic activity were cDNA sequence. The reaction mixture contained 250 made both of total HBG activity representing the endogmol/L of each desoxynucleoside triphosphate (dNTP), enous murine HBG activity and any human HBG activity 2.5 units of Amplitaq Gold (Perkin Elmer, Foster City, resulting from gene transfer, immunoprecipitation of hu-CA, USA), 2.5 mmol/L MgCl 2 , and 0.5 mol/L of each man HBG was performed to estimate the human HBG primer in Amplitaq buffer. Thermal cycling was peractivity only. Each sample was divided into two identical formed on Takara PCR Thermal cycler MP (Takara aliquots and the human HBG was immunoprecipitated Shuzo Co., Ltd.) as follows: 95ЊC for 5 minutes for initial from one of each pair. Ten micrograms of protein of denaturing, followed by 63 cycles of 94ЊC for 1 minute, each homogenate were mixed with either 10 L of anti-60ЊC for 1 minute, and 60ЊC for 5 minutes for the final human HBG or distilled water, and shaken at 4ЊC for 1 extension cycle. After electrophoresis in a 2% agarose hour. Twenty five microliters of protein A sepharose 4 gel, the amplified products were visualized with ethidium fast flow (Amersham Pharmacia Biotech, Buckinghambromide staining. Experiments were performed in quashire, UK) was then added to each of the samples, which were inverted overnight at 4ЊC. Samples were spun at druplicate and representative pictures are shown. 12,000g for 2 minutes and supernatant removed for measurement of HBG enzymatic activity.
Western blot analysis
Western blot analysis was performed to measure the secretion of HBG from recruited human CD14 ϩ cells in the glomeruli as described [6] . Briefly, homogenates of isolated glomeruli (2 g) from LPS-treated and salinetreated mice were subjected to electrophoresis in a 12.5% sodium dodecyl sulfate-polyacrylamide gel and then transferred to nitrocellulose membrane. The membrane was blocked with 5% dried milk, 0.1% Tween 20, PBS, and incubated with anti-human HBG antibody (ϫ1000). It was then incubated with rabbit anti-gout immunoglobulin horseradish peroxidase conjugate (Cosmo Bio, Tokyo, Japan). Antigen-antibody complexes were visualized by chemiluminescence reagents (Amersham Pharmacia Biotech).
Analysis of proteinuria and serum creatinine
The concentration of albumin in urine was measured by single radial immunodiffusion (SRID) [23] using a specific antibody for mouse albumin [24] . Briefly, samples were applied to a 1% agarose gel containing antimouse albumin and incubated for 48 hours. The diame- 
Statistical analysis
Data are expressed as mean Ϯ SE. Statistical analysis was performed using the two-sample t test to compare data in different groups. P Ͻ 0.05 was found to be significant. are susceptible to retroviral transfection in the precommited form.
RESULTS

Establishment of chimera mouse that has mouse body Susceptibility of CD34
؉ cord blood cells to with human hematopoietic system retroviral transfection
To establish the chimera mouse, the hematopoietic To examine the efficacy of CD34 ϩ cord blood cells systems were exchanged for human cells, and HBGto retroviral transfection, CD34 ϩ cells were established transfected CD34 ϩ cells were transplanted to NOD/ from freshly obtained human cord blood cells and retro-SCID mice. After 8 weeks, bone marrow cells from these virally transfected with the human HBG gene, using mice were subjected to flow cytometric analysis on hucentrifugation methods with concentrated viral supernaman HLA ABC antigen. As shown in Figure 2A , 24.1 Ϯ tant. These cells were cultured in MethoCult GF H4434V 14.5% of bone marrow cells in these chimera mice exfor 14 days and DNA from each colony was subjected pressed human HLA ABC antigen, showing successful to PCR on the HBG gene. As shown in Figure 1 , three chimerism in these mice. To confirm that these reconstidifferent lineages of hematopoietic cell possessed the tuted bone marrow cells still maintained the transgene transgene (88.4 Ϯ 5.9% in BFU-E, 79.7 Ϯ 11.4% in clonogenic assay was also performed on HBG. As shown CFU-E, and 81.1 Ϯ 14.1% in CFU-G, respectively), and in Figure 2B , the cells from these marrows still possessed there were no significant differences between lineages, the transgene (31.4 Ϯ 10.8% in BFU-E, 38.9 Ϯ 18.9% in CFU-E, and 33.8 Ϯ 19.9% in CFU-G, respectively), suggesting that CD34 ϩ cells from human cord blood cells showing a sustained engraftment of human hematopoi-HBG. The total HBG enzymatic activity in isolated glomeruli was not significantly elevated by LPS treatment etic cells expressing the HBG gene.
(716.0 Ϯ 68.8 nmol/hr/mg in saline-treated mice vs.
Delivery into inflamed site by in vivo differentiated
1085.9 Ϯ 137.5 nmol/hr/mg in LPS-treated mice; P ϭ human cells 0.0821) (Fig. 3B) . However, transplanted human HBG activity, which was estimated by subtraction of endogeSince Verstegan et al [25] previously reported that nous murine HBG activity from total HBG, was signifihuman monocytes may spontaneously grow out in the cantly elevated by LPS treatment (148.1 Ϯ 52.0 nmol/ SCID mice after transplantation with unfractionated huhr/mg in saline-treated mice vs. 574.8 Ϯ 102.7 nmol/ man cord blood cells, we speculated that transplanted hr/mg in LPS-treated mice; P ϭ 0.0041). Furthermore, human CD34 ϩ cells may differentiate into mononuclear Western blot analysis revealed that isolated glomeruli cells and effectively deliver transgene into inflamed glomeruli. Chimera mice were treated with LPS or saline from LPS-treated chimera mice contained higher amount of HBG protein compared with control chimera mice once daily for 7 days and subjected to immmunohistochemical analysis, HBG enzymatic assay, and Western (Fig. 3C) . Together, these data suggested that umbilical cord blood-derived CD34 ϩ cells might differentiate into blot analysis of HBG expression. At day 7, kidneys were obtained from these mice and tissue sections were monocyte lineage cells while maintaining the expression of the foreign gene. stained with human CD14 and HBG. As shown in Figure  3A , CD14 ϩ cells were detected in the glomeruli upon Although native macrophages may influence the behavior of donor macrophages, only a negligible number LPS treatment, and 19.3 Ϯ 4.4% of those cells secreted (ICAM-1) expression in the glomeruli without competition with native macrophages, by which the significance of transgene activity might be enhanced. On the other hand, recruitment of transplanted cells into glomeruli might affect renal function and, therefore, renal function after LPS treatment was examined in chimera mice. Both urine albumin and serum creatinine levels were under detectable level (the lowest detectable concentrations of albumin and creatinine are 20 mg/mL and 0.3 mg/dL, respectively), suggesting that accumulation of exogenous human CD14 cells, per se, did not affect renal function in chimera mice.
DISCUSSION
Transplantation-based gene therapy has been proposed as a novel therapeutic strategy for chronic inflammatory diseases such as glomerulonephritis [5] . This approach is based on the fact that inflammatory cells such as macrophages and neutrophils are capable of being recruited to and activated at the inflamed glomeruli and, therefore, genetic manipulation of bone marrow-derived cells or bone marrow, per se, using transplantation-based technology may modify inflammation. We previously reported that bone marrow reconstitution using genetically-modified hematopoietic progenitor cells to supply anti-inflammatory mononuclear cells to inflamed glomeruli confer resistance against glomerular inflammation [7] . As the next step toward the clinical use, we investigated the suitability of human umbilical cord blood as a source of hematopoietic stem cells, which may reduce the risks to patients, and showed that CD34 ϩ cells than that of adult T cells, which may underlie umbilical M is molecular weight marker.
cord blood reduced graft-versus-host reactivity [30, 31] . Although these advantages strengthen the rational of its clinical use, there are several obstacles to be overcome. First, the efficacy of retroviral transfection is quite low of native macrophages could be detected in the glomeruli for human stem cells compared to mouse stem cells [32] . of the NOD/SCID mice treated with LPS (data not
We tried several different methods and finally concluded shown), probably because the number of native macrothat the most efficient transfection was done by a centrifphages in NOD/SCID mice are small [26] and are funcugation method [14] using recombinant human fibrotionally immature [27] , especially when the response to nectin fragment CH-286-coated tubes [18] with concen-LPS is impaired [28] . Therefore, donor macrophages may occupy the area of intercellular adhesion molecule-1 trated viral supernatant [17] . This modification resulted in the highest efficacy among our retrovirus-based transwhether bone marrow progenitor cells may maintain this regulation during the differentiation in our laboratory. duction attempt. However, it may not be sufficient for Recently, stem cell therapy has advanced with the therapeutic intervention, especially if the antagonist is discovery of several stem cells. We previously reported, used to cancel the effect of inflammatory cytokines. In using transplantation technology, that mesangial progenterms of clinical application, further modification is itor cells might exist in bone marrow cells [44] , most needed. In this regard, attempts to establish a novel likely in the fraction of mesenchymal stem cells because vector system, such as lentivirus vectors based on the donor cells did not differentiate into residential mesanhuman immunodeficiency virus, have been made [33] .
gial cells when bone marrow was transplanted after elimThe use of these vectors, however, raises concerns about ination of mesenchymal stem cells by culture in IL-3, their safety, which must be completely cleared before IL-6, and SCF for 72 hours [7] . Therefore, we have proclinical use. Another approach to overcome the low gene posed two different therapeutic strategies for glomerular transfection efficacy is selection or expansion of transdiseases, depending upon whether to differentiate bone fected stem cells ex vivo [34, 35] bined with a Cre/loxP system [42] , so that transgene IL-1␤ was produced [43] . Currently it is being examined
